CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Hypoxanthine 100mg  | ≥99%

CSNpharm

Hypoxanthine, a naturally occurring purine derivative, an intermediate product of uric acid synthesis, formed from adenylic acid and itself a precursor of xanthine.

More Information Supplier Page

Hypoxanthine 50mg  | ≥99%

CSNpharm

Hypoxanthine, a naturally occurring purine derivative, an intermediate product of uric acid synthesis, formed from adenylic acid and itself a precursor of xanthine.

More Information Supplier Page

i-Inositol 5g  | ≥98%

CSNpharm

i-Inositol is a chemical compound, associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.

More Information Supplier Page

i-Inositol 1g  | ≥98%

CSNpharm

i-Inositol is a chemical compound, associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.

More Information Supplier Page

IAA-94 100mg  | ≥98%

CSNpharm

IAA-94 is an indanyloxyacetic acid (IAA) inhibitor of chloride channels that binds channels in bovine kidney cortex microsomes with a Ki value of 1 µM.

More Information Supplier Page

IAA-94 50mg  | ≥98%

CSNpharm

IAA-94 is an indanyloxyacetic acid (IAA) inhibitor of chloride channels that binds channels in bovine kidney cortex microsomes with a Ki value of 1 µM.

More Information Supplier Page

IB-MECA 5mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page

IB-MECA 25mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page

IB-MECA 50mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page

IB-MECA 10mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page

IB-MECA 2mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page

IBMX 50mg  | ≥99%

CSNpharm

IBMX is a competitive nonselective PDEs inhibitor and a nonselective adenosine receptor antagonist, with IC50 of 2-50 μM but does not inhibit PDE8 or PDE9.

More Information Supplier Page

Ibotenic Acid 50mg  | ≥95%

CSNpharm

Ibotenic acid has agonist activity at both the N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolotropic quisqualate (Qm) receptor sites.

More Information Supplier Page

Ibotenic Acid 25mg  | ≥95%

CSNpharm

Ibotenic acid has agonist activity at both the N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolotropic quisqualate (Qm) receptor sites.

More Information Supplier Page

Ibotenic Acid 1mg  | ≥95%

CSNpharm

Ibotenic acid has agonist activity at both the N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolotropic quisqualate (Qm) receptor sites.

More Information Supplier Page

Ibotenic Acid 10mg  | ≥95%

CSNpharm

Ibotenic acid has agonist activity at both the N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolotropic quisqualate (Qm) receptor sites.

More Information Supplier Page

Ibotenic Acid 5mg  | ≥95%

CSNpharm

Ibotenic acid has agonist activity at both the N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolotropic quisqualate (Qm) receptor sites.

More Information Supplier Page

Ibudilast 100mg  | ≥99%

CSNpharm

Ibudilast is a nonselective phosphodiesterase inhibitor with IC50s of 53, 35, 48, 12 and 10 μM for PDE Ia, II, III, IV and V respectively, which has been marketed for treating asthma.

More Information Supplier Page

Ibudilast 50mg  | ≥99%

CSNpharm

Ibudilast is a nonselective phosphodiesterase inhibitor with IC50s of 53, 35, 48, 12 and 10 μM for PDE Ia, II, III, IV and V respectively, which has been marketed for treating asthma.

More Information Supplier Page

Ibudilast 10mg  | ≥99%

CSNpharm

Ibudilast is a nonselective phosphodiesterase inhibitor with IC50s of 53, 35, 48, 12 and 10 μM for PDE Ia, II, III, IV and V respectively, which has been marketed for treating asthma.

More Information Supplier Page

Ibuprofen 5g  | ≥99%

CSNpharm

Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50 of 13 μM and 370 μM, respectively, and is used for pain relief, fever reduction and for reducing swelling.

More Information Supplier Page

Ibuprofen piconol 100mg  | ≥96%

CSNpharm

Ibuprofen piconol is a non-steroidal, anti-inflammatory (NSAID) agent for the topical relief of primary thermal burns and sunburns.

More Information Supplier Page

IC261 25mg  | ≥98%

CSNpharm

IC261 is an ATP-competitive inhibitor of CK1 with IC50s about 1 μM for CK1δ and CK1ε, 16 μM for CK1α.

More Information Supplier Page

IC261 50mg  | ≥98%

CSNpharm

IC261 is an ATP-competitive inhibitor of CK1 with IC50s about 1 μM for CK1δ and CK1ε, 16 μM for CK1α.

More Information Supplier Page

IC261 5mg  | ≥98%

CSNpharm

IC261 is an ATP-competitive inhibitor of CK1 with IC50s about 1 μM for CK1δ and CK1ε, 16 μM for CK1α.

More Information Supplier Page

IC261 1mg  | ≥98%

CSNpharm

IC261 is an ATP-competitive inhibitor of CK1 with IC50s about 1 μM for CK1δ and CK1ε, 16 μM for CK1α.

More Information Supplier Page

IC261 10mg  | ≥98%

CSNpharm

IC261 is an ATP-competitive inhibitor of CK1 with IC50s about 1 μM for CK1δ and CK1ε, 16 μM for CK1α.

More Information Supplier Page